Extracellular matrix remodeling and matrix metalloproteinases in the vascular wall during aging and in pathological conditions

Biomedicine and Pharmacotherapy

Volumn 57, Issue 5-6, 2003, Pages 195-202

  Jacob, Marie Paule ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

Collagens; Elastases; Elastin; Matrix metalloproteinases; Vascular wall

Indexed keywords

COLLAGEN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ELASTIN; ENZYME INHIBITOR; ENZYME PRECURSOR; GLYCOPROTEIN; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR; PROTEINASE; PROTEINASE INHIBITOR; PROTEOGLYCAN;

AGING; ANEURYSM; ARTICLE; BLOOD VESSEL WALL; DRUG EFFECT; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME RELEASE; EXTRACELLULAR MATRIX; FETUS DEVELOPMENT; GENE EXPRESSION; GENE INDUCTION; HUMAN; HYPERTENSION; INFLAMMATORY CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SYNTHESIS; SMOOTH MUSCLE FIBER; VARICOSIS; VASCULAR DISEASE;

EID: 0042347601     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0753-3322(03)00065-9     Document Type: Article

References (64)

1. Allaire E., Hasenstab D., Kenagy R.D., Starcher B., Clowes M.M., Clowes A.W. Prevention of aneurysm development and rupture by local overexpression of plasminogen activator inhibitor-1. Circulation. 98:1998;249-255.
2. Allaire E., Forough R., Clowes M., Starcher B., Clowes A.W. Local overexpression of TIMP-1 prevents aortic aneurysm degeneration and rupture in a rat model. J Clin Invest. 102:1998;1413-1420.
3. Allaire E., Muscatelli-Groux B., Mandet C., Guinault A.M., Bruneval P., Desgranges P., et al. Paracrine effect of vascular smooth muscle cells in the prevention of aortic aneurysm formation. J Vasc Surg. 36:2002;1018-1026.
4. Badier-Commander C., Verbeuren T., Lebard C., Michel J.B., Jacob M.P. Increased TIMP/MMP ratio in varicose veins: a possible explanation for extracellular matrix accumulation. J Pathol. 192:2000;105-112.
5. Badier-Commander C., Couvelard A., Henin D., Verbeuren T., Michel J.B., Jacob M.P. Smooth muscle cell modulation and cytokine overproduction in varicose veins. An in situ study. J Pathol. 193:2001;398-407.
6. Bieth J.G. Leukocyte elastase. Barrett A.J., Rawlings N.D., Woessner J.F. Handbook of proteolytic enzymes. 1998;54-60 Academic Press, San Diego.
7. Brew K., Dinakarpandian D., Nagase H. Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim Biophys Acta. 1477:2000;267-283.
8. Chothia C., Jones E.Y. The molecular structure of cell adhesion molecules. Ann Rev Biochem. 66:1997;823-862.
9. Collod G., Boileau C. Fibrillines et fibrillinopathies. Méd/Sci. 12:1996;1077-1086.
10. Curci J.A., Liao S., Huffman M.D., Shapiro S.D., Thompson R.W. Expression and localization of macrophage elastase (matrix metalloproteinase-12) in abdominal aortic aneurysms. J Clin Invest. 102:1998;1900-1910.
11. Debelle L., Tamburro A.M. Elastin: molecular description and function. Int J Biochem Cell Biol. 31:1999;261-272.
12. Devy L., Noël A., Cataldo D., Jeannesson P., Foidart J.M. Rôle des métalloprotéinases matricielles et des protéases à sérine dans la migration et l'infiltration des cellules hématopoïétiques. Hématologie. 5:1999;265-272.
13. Dietz H.C., Mecham R.P. Mouse models of genetic diseases resulting from mutations in elastic fiber proteins. Matrix Biol. 19:2000;481-488.
14. Dollery C.M., McEwan J.R., Henney A.M. Matrix metalloproteinases and cardiovascular disease. Circ Res. 77:1995;863-868.
15. Feldman L.J., Mazighi M., Scheuble A., Deux J.F., De Benedetti E., Badier-Commander C., et al. Differential expression of matrix metalloproteinases after stent implantation and balloon angioplasty in the hypercholesterolemic rabbit. Circulation. 103:2001;3117-3122.
16. Fontaine V., Jacob M.P., Houard X., Rossignol P., Plissonnier D., Angles-Cano E., et al. Involvement of the mural thrombus as a site of protease release and activation in human aortic aneurysms. Am J Pathol. 161:2002;1701-1710.
17. Fukuda S., Hashimoto N., Naritomi H., Nagata I., Nozaki K., Kondo S., et al. Prevention of rat cerebral aneurysm formation by inhibition of nitric oxide synthase. Circulation. 101:2000;2532-2538.
18. Galis Z.S., Khatri J.J. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ Res. 90:2002;251-262.
19. Gonzalez W., Fontaine V., Pueyo M.E., Laquay N., Messika-Zeitoun D., Philippe M., et al. Molecular plasticity of vascular wall during Nω-nitro-L-arginine methyl ester-induced hypertension: modulation of proinflammatory signals. Hypertension. 36:2000;103-109.
20. Gibson M.A., Hatzinikolas G., Kumaratilake J.S., Sandberg L.B., Nicholl J.K., Sutherland G.R., et al. Further characterization of proteins associated with elastic fiber microfibrils including the molecular cloning of MAGP-2 (MP25). J Biol Chem. 271:1996;1096-1103.
21. Handford P.A., Downing A.K., Reinhardt D.P., Sakai L.Y. Fibrillin: from domain structure to supramolecular assembly. Matrix Biol. 19:2000;457-470.
22. Herron G.S., Unemori E.N., Stoney R.J. Proteinases and inhibitors in aortic aneurysms. Weber K.T. Wound healing in cardiovascular disease. 1995;195-209 Futura Publishing Company, Armonk.
23. Hornstra I.K., Birge S., Starcher B., Bailey A.J., Mecham R.P., Shapiro S.D. Lysyl oxidase is required for vascular and diaphragmatic development in mice. J Biol Chem. 278:2003;14387-14393.
24. Iozzo R.V. Matrix proteoglycans: from molecular design to cellular function. Ann Rev Biochem. 67:1998;609-652.
25. Jacob M.P. Elastine: préparation, caractérisation, structure, biosynthèse et catabolisme. C R Soc Biol. 187:1993;166-180.
26. Jacob M.P., Cazaubon M., Scemama A., Prie D., Blanchet F., Guillin M.C., et al. Plasma matrix metalloproteinase-9 as a marker of blood stasis in varicose veins. Circulation. 106:2002;535-538.
27. Keeley F.W., Alatawi A. Response of aortic elastin synthesis and accumulation to developing hypertension and the inhibitory effect of colchicine on this response. Lab Invest. 64:1991;499-507.
28. Keeley F.W., Elmoselhi A., Leenen F.H. Effects of antihypertensive drug classes on regression of connective tissue components of hypertension. J Cardiovasc Pharmacol. 17:1991;S64-S69.
29. Keeley F.W., Elmoselhi A., Leenen F.H. Enalapril suppresses normal accumulation of elastin and collagen in cardiovascular tissues of growing rats. Am J Physiol. 262:1992;H1013-H1021.
30. Kielty C.M., Sherratt M.J., Shuttleworth C.A. Elastic fibres. J Cell Sci. 115:2002;2817-2828.
31. Knox J.B., Sukhova G.K., Whittemore A.D., Libby P. Evidence for altered balance between matrix metalloproteinases and their inhibitors in human aortic diseases. Circulation. 95:1997;205-212.
32. Labat-Robert J. Cell-matrix interactions, alterations with aging, involvement in angiogenesis. Pathol Biol. 46:1998;527-533.
33. Lakatta E.G., Levy D. Arterial and cardiac aging. Major shareholders in cardiovascular disease enterprises. Part I: aging arteries: a "set up" for vascular disease. Circulation. 107:2003;139-146.
34. Lakatta E.G. Arterial and cardiac aging. Major shareholders in cardiovascular disease enterprises. Part III: cellular and molecular clues to heart and arterial aging. Circulation. 107:2003;490-497.
35. Laviades C., Varo N., Fernandez J., Mayor G., Gil M.J., Monreal I., et al. Abnormalities of the extracellular degradation of collagen type I in essential hypertension. Circulation. 98:1998;535-540.
36. Li D.Y., Faury G., Taylor D.G., Davis E.C., Boyle W.A., Mecham R.P., et al. Novel arterial pathology in mice and humans hemizygous for elastin. J Clin Invest. 102:1998;1783-1787.
37. Li D.Y., Brooke B., Davis E.C., Mecham R.P., Sorensen L.K., Boak B.B., et al. Elastin is an essential determinant of arterial morphogenesis. Nature. 393:1998;276-280.
38. Li Z., Froehlich J., Galis Z.S., Lakatta E.G. Increased expression of matrix metalloproteinase-2 in the thickened intima of aged rats. Hypertension. 33:1999;116-123.
39. Lopez-Candales A., Holmes D.R., Liao S., Scott M.J., Wickline S.A., Thompson R.W. Decreased vascular smooth muscle cell density in medial degeneration of human abdominal aortic aneurysms. Am J Pathol. 150:1997;993-1007.
40. Lortat-Jacob H., Grosdidier A., Imberty A. Structural diversity of heparan sulfate binding domains in chemokines. Proc Natl Acad Sci USA. 99:2002;1229-1234.
41. Maki J.M., Rasanen J., Tikkanen H., Sormunen R., Makikallio K., Kivirikko K.I., et al. Inactivation of the lysyl oxidase gene Lox leads to aortic aneurysms, cardiovascular dysfunction, and perinatal death in mice. Circulation. 106:2002;2503-2509.
42. Mayne R. Collagenous proteins of blood vessels. Arteriosclerosis. 6:1986;585-593.
43. Michel J.B., Heudes D., Michel O., Poitevin P., Philippe M., Scalbert E., et al. Effect of chronic ANG I-converting enzyme inhibition on aging processes. II. Large arteries. Am J Physiol. 267:1994;R124-R135.
44. Michel J.B. Acquired abdominal aortic aneurysm. Nephrol Dial Transpl. 13:(Suppl 4):1998;20-24.
45. Michel J.B. Contrasting outcomes of atheroma evolution: intimal accumulation versus medial destruction. Arterioscler Thromb Vasc Biol. 21:2001;1389-1392.
46. Michiels C., Arnould T., Remacle J. Endothelial cell responses to hypoxia: initiation of a cascade of cellular interactions. Biochim Biophys Acta. 1497:2000;1-10.
47. Milewicz D.M., Urban Z., Boyd C. Genetic disorders of the elastic fiber system. Matrix Biol. 19:2000;471-480.
48. Nakamura T., Lozano P.R., Ikeda Y., Iwanaga Y., Hinek A., Minamisawa S., et al. Fibulin-5/DANCE is essential for elastogenesis in vivo. Nature. 415:2002;171-175.
49. Praillet C., Grimaud J.A., Lortat-Jacob H. Les protéoglycannes. I. Molécules aux multiples fonctions . futures molécules thérapeutiques? Méd/Sci. 14:1998;412-420.
50. Prockop D.J., Kivirikko K.I. Collagens: molecular biology, diseases, and potentials for therapy. Ann Rev Biochem. 64:1995;403-434.
51. Rabinovitch M. EVE and beyond, retro and prospective insights. Am J Physiol. 277:1999;L5-L12.
52. Reiser K., McCormick R.J., Rucker R.B. Enzymatic and non-enzymatic cross-linking of collagen and elastin. FASEB J. 6:1992;2439-2449.
53. Robert L. Les protéases de type élastase. Pathol Biol. 36:1988;1101-1107.
54. Robins S.P., Farquharson C. Connective tissue components of the blood vessel wall in health and disease. Stehbens W.E., Lie J.T. Vascular pathology. 1995;89-127 Chapman & Hall Medical, London.
55. Rosenbloom J., Abrams W.R., Mecham R. Extracellular matrix. 4: The elastic fiber. FASEB J. 7:1993;1208-1218.
56. Sangiorgi G., D'Averio R., Mauriello A., Bondio M., Pontillo M., Castelvecchio S., et al. Plasma levels of metalloproteinases-3 and -9 as markers of successful abdominal aortic aneurysm exclusion after endovascular graft treatment. Circulation. 104:2001;I288-I295.
57. Shapiro S.D., Endicott S.K., Province M.A., Pierce J.A., Campbell E.J. Marked longevity of human lung parenchymal elastic fibers deduced from prevalence of D-aspartate and nuclear weapons-related radiocarbon. J Clin Invest. 87:1991;1828-1834.
58. Tamarina N.A., McMillan W.D., Shively V.P., Pearce W.H. Expression of matrix metalloproteinases and their inhibitors in aneurysms and normal aorta. Surgery. 122:1997;264-272.
59. Thompson R.W., Holmes D.R., Mertens R.A., Liao S., Botney M.D., Mecham R.P., et al. Production and localization of 92-kDa gelatinase in abdominal aortic aneurysms. An elastolytic metalloproteinase expressed by aneurysm-infiltrating macrophages. J Clin Invest. 96:1995;318-326.
60. van der Rest M., Garrone R. Collagen family of proteins. FASEB J. 5:1991;2814-2823.
61. Visse R., Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res. 92:2003;827-839.
62. Wang M., Lakatta E.G. Altered regulation of matrix metalloproteinase-2 in aortic remodeling during aging. Hypertension. 39:2002;865-873.
63. Werb Z., Banda M.J., McKerrow J.H., Sandhaus R.A. Elastases and elastin degradation. J Invest Dermatol. 79:1982;154s-159s.
64. Yanagisawa H., Davis E.C., Starcher B.C., Ouchi T., Yanagisawa M., Richardson J.A., et al. Fibulin-5 is an elastin-binding protein essential for elastic fibre development in vivo. Nature. 415:2002;168-171.